Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective/Background: To evaluate the prevalence of hyposmia and dysgeusia in patients with SARS-CoV-2 infection and their temporal relationship with the onset of other symptoms.
Methods: We performed a retrospective analysis of patients admitted during the month of March 2020 to the non-intensive Covid unit of Udine University Hospital on the basis of a positive swab test and/or of clinical-radiological signs of SARS-CoV-2 infection. Patients were interviewed with a standardized questionnaire. Clinical and laboratory data were collected. Data were analyzed with descriptive statistics and results expressed as point estimates and 95% confidence intervals.
Results: Of 141 patients admitted, 93 were interviewed. Hyposmia and dysgeusia were present in 58 cases (62.4%). In 22.4% of them, olfactory and gustatory impairment clearly preceded systemic symptoms. The presence of active smoking was very limited in both groups: 8.6% in hyposmic vs 2.9% in normosmic patients [OR= 3.2 CI 95% (0.3 to 28.6)]. Moreover, total leukocytes and neutrophils count were respectively 23% [effect estimate 1.23 CI 95% (1.06 to 1.42)] and 29% [effect estimate 1.29 CI 95% (1.07 to 1.54)] lower in the hyposmic cohort. No difference was found for other inflammatory biomarkers.
Conclusions: Hyposmia and dysgeusia are common in SARS-Cov-2 infection and can precede systemic symptoms. They should be actively searched and prompt close monitoring and isolation until infection is confirmed or disproven. The lower number of total leukocytes and neutrophils in hyposmic patients might indicate an early phase virus-induced cytopenia.
- Received April 29, 2020.
- Accepted November 16, 2020.
- © 2020 American Academy of Neurology
The Nerve!: Rapid online correspondence
NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.cp.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.